A graphene quantum dot photodynamic therapy agent with high singlet oxygen generation

Area of Science:

• Nanomaterials Science
• Photochemistry
• Biomedical Engineering

Background:

• Current photodynamic therapy (PDT) agents have limitations including low singlet oxygen ((1)O2) quantum yields, photobleaching, and poor biocompatibility.
• These limitations hinder the clinical efficacy and broad application of existing PDT treatments.

Purpose of the Study:

• To develop a novel photodynamic therapy agent with improved performance over existing agents.
• To utilize graphene quantum dots (GQDs) for enhanced (1)O2 production and cancer therapy.
• To explore the potential of GQDs for simultaneous imaging and therapeutic applications.

Main Methods:

• Synthesis and characterization of graphene quantum dots (GQDs).
• Investigation of the (1)O2 production mechanism via multistate sensitization.
• Evaluation of GQD absorption and emission properties.
• In vitro and in vivo studies to assess efficacy in cancer therapy and imaging.

Main Results:

• GQDs demonstrated a high (1)O2 quantum yield of approximately 1.3, the highest reported for PDT agents.
• GQDs exhibit broad absorption across UV-visible regions and strong deep-red emission.
• In vitro and in vivo studies confirmed GQDs' effectiveness as PDT agents for cancer therapy and imaging.

Conclusions:

• Graphene quantum dots represent a new generation of carbon-based nanomaterial PDT agents.
• GQDs offer superior performance in (1)O2 quantum yield, water dispersibility, photo- and pH-stability, and biocompatibility compared to conventional agents.
• This advancement holds promise for more effective and versatile cancer treatments.